Cross-Reactive Antibodies to Butyrophilins in Myelin Oligodendrocyte Glycoprotein Antibody Disease. (P7-8.020)
To analyze autoantibodies against human BTN1A1, BTN2A1, BTN3A1, CD80, CD86, PD-L1 (programmed death ligand 1), and bovine BTN1A1 using novel cell-based assays in MOGAD patient sera comparing to aquaporin-4 antibody seropositive NMOSD patients and healthy controls.
Authors
- Philippe‐Antoine Bilodeau (ORCID: https://orcid.org/0000-0002-2672-554X)
- Monique Anderson (ORCID: https://orcid.org/0000-0001-7713-2878)
- Shuhei Nishiyama (ORCID: https://orcid.org/0000-0002-0248-1595)
- Natalia Drosu
- Natasha Bobrowski‐Khoury (ORCID: https://orcid.org/0000-0002-6946-3711)
- Takahisa Mikami (ORCID: https://orcid.org/0000-0003-1851-5259)
- Michael Levy (ORCID: https://orcid.org/0000-0002-7969-8346)
Institutions
- Harvard University (US)
- Tohoku University (JP)
- Massachusetts General Hospital (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000211690
- Primary Topic
- Immunodeficiency and Autoimmune Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00